過敏性腸症候群 (IBS) 治療市場は、2020 年に 21 億 5,389 万米ドルと評価され、2028 年までに 46 億 300 万米ドルに達すると予測されています。 2021 年から 2028 年まで 10.1% の CAGR で成長すると予想されています。
過敏性腸症候群の有病率の増加や研究開発活動の増加などの主な要因が市場の成長を推進します。しかし、入手可能な製品の数が限られていることと治療の非効率性が市場の成長を抑制しています。 IBS は、腹部臓器である大腸に影響を及ぼす一般的な慢性疾患です。痙性結腸、粘液性大腸炎、過敏性結腸、痙性結腸炎としても知られています。この状態は炎症性腸疾患とは大きく異なります。けいれん、腹痛、膨満感、ガス、下痢または便秘、あるいはその両方などの症状が現れます。症状が軽い場合は、ストレス、ライフスタイル、食事を変えることで対処できます。一方、重篤な症状の場合は投薬とカウンセリングで治療します。
APAC では、新型コロナウイルス感染症 (COVID-19) の原因となる新型コロナウイルスの蔓延を阻止するために多くの対策が実施されています。この措置により、医療業界を含むさまざまな業界の多くの企業の経営が混乱しました。従業員の隔離、サプライチェーンの障害、需要の減少が企業に深刻な問題を引き起こしています。また、私立病院チェーンでは入院患者および外来患者のケアが大幅に減少している。医療システムを緩和するために、多くのクリニックは重要でない予約を延期しています。このシナリオは、過敏性腸症候群 (IBS) 治療の成長を妨げています。
過敏性腸症候群 (IBS) 治療市場にとって有利な地域
市場に関する洞察
過敏性腸症候群と関連疾患の有病率の増加
過敏性腸症候群は、排便習慣の乱れや腹痛によって引き起こされる主に観察される慢性胃腸疾患です。 。この疾患は、痙性結腸、過敏性結腸、粘液性結腸炎、および痙性結腸炎としても知られています。過敏性腸症候群では、腹痛、便秘、下痢、けいれんなどの症状が現れます。地域全体の医療システムでは、過敏性腸症候群の発生率が大幅に増加しています。国際胃腸障害財団が発表したデータによると、全IBS患者のうち、約40%の患者が軽度のIBSを患い、約35%が中等度のIBSを患い、推定25%が重度のIBSを患っているとしている。多くの人は過敏性腸症候群の症状に気づいていません。
食物アレルギー、胃腸炎の進行段階、散発的な結腸の動き、結腸内のセロトニン組成の異常、軽度のセリアック病などの特定の要因は、IBS を引き起こす可能性のある危険因子です。これらの要因により、世界中で過敏性腸症候群の罹患率が加速すると予測されています。たとえば、2018 年に NCBI で発表された研究によると、IBS は毎年米国人口の約 10% ~ 16% に影響を及ぼしていると推定されています。このような IBS の驚異的な有病率は、予測期間中に過敏性腸症候群 (IBS) 治療市場を押し上げる可能性があります。
タイプベースの洞察
タイプに基づいて、過敏性腸症候群 (IBS) 治療市場は混合型 IBS (IBS-M)、下痢を伴う IBS (IBS-D) に分類されます。 、および便秘を伴うIBS(IBS-C)。 2020年には、混合型IBS(IBS-M)セグメントが市場で最大のシェアを占めました。また、同じセグメントが予測期間中に最高の CAGR を記録すると予想されます。女性と男性の間でIBSの有病率が上昇しているため、便秘と下痢の複合症状を治療できる医薬品の需要が高まることが予想されます。 IBSの有病率は高齢化が進むにつれてより高くなります。したがって、混合型IBSを治療するための医薬品の需要は、予測期間中に大幅に増加する可能性があります。
タイプ別過敏性腸症候群(IBS)治療市場 - 2020年および2028年
製品ベースの洞察
製品に基づいて、過敏性腸症候群 (IBS) 治療市場はリファキシミン、エルキサドリン、ルビプロストン、リナクロチドなどに分類されます。リナクロチドセグメントは、2020年の市場で最大のシェアを占めました。また、同じセグメントは、予測期間中に市場で最高のCAGRを記録すると推定されています。このセグメントの市場成長は、リナクロチドのジェネリック版の製造の増加や、IBS治療用のリナクロチドの開発と商品化に向けた市場統合の高まりなどの要因によるものと考えられます。
流通チャネルベースの洞察
流通チャネルに基づいて、過敏性腸症候群 (IBS) 治療市場は病院の薬局、ドラッグ ストアと小売薬局、オンライン薬局に分類されます。 2020年には、病院薬局セグメントが市場で最大のシェアを占めました。ただし、ドラッグ ストアおよび小売薬局セグメントは、予測期間中に最も高い CAGR を記録すると予想されます。
戦略的洞察
過敏性腸症候群 (IBS) 治療市場で事業を展開する企業は、世界中で進化する顧客の要求を満たすための製品革新戦略により、顧客は世界市場でブランド名を維持することができます。
過敏性腸症候群 (IBS) 治療市場 - タイプ別
- 下痢を伴う IBS (IBS-D)
- 便秘を伴う IBS (IBS-C) )
- 混合型 IBS (IBS-M)
過敏性腸症候群 (IBS) 治療市場 - 製品別
- リファキシミン
- エルクサドリン
- リナクロチド
- ルビプロストン
- その他
過敏性腸症候群(IBS)治療市場 -流通チャネル別
- 病院薬局
- ドラッグストアおよび小売薬局
- オンライン薬局
過敏性腸症候群(IBS) 治療市場 - 地域別
- 北米
- 米国
- カナダ
- メキシコ
- ヨーロッパ
- フランス
- ドイツ
- イタリア
- イギリス
- スペイン
- その他のヨーロッパ
- アジア太平洋 (APAC)
- 中国
- インド
- 韓国
- 日本
- オーストラリア
- アジア太平洋地域のその他の地域
- 中東およびアフリカ (MEA)
- 南アフリカ
- サウジアラビア
- アラブ首長国連邦
- MEAの残りの部分
- 中南米 (SCAM)
- ブラジル
- アルゼンチン
- その他の SCAM
会社概要
- Ironwood Pharmaceuticals, Inc.
- AbbVie.
- Sebela Pharmaceuticals, Inc.
- 武田薬品工業株式会社
- アルファシグマ SpA
- アステラス製薬株式会社
- アストラゼネカ
- 合成生物製剤株式会社
- ボシュロム法人化
- Lannett Company Inc
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Irritable bowel syndrome (IBS) is a common disorder that affects the abdominal organ, large intestine. It is also known as spastic colon, mucous colitis, irritable colon, and spastic colitis. The condition is much different than inflammatory bowel disease. However, it is a chronic condition which a person must manage for a longer period. It shows symptoms such as cramping, abdominal pain, bloating, gas, and diarrhea or constipation, or both at the same. These symptoms can be managed by changing stress, lifestyle, and diet. And the more severe symptoms are treated with medication and counseling.
The factors that are driving growth of the market are increasing prevalence of irritable bowel syndrome diseases and increasing research & development activities.
The irritable bowel syndrome (IBS) treatment market majorly consists of the players such as Ironwood Pharmaceuticals, Inc., AbbVie., Sebela Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited, Alfasigma S.p.A., Astellas Pharma Inc., AstraZeneca, Synthetic Biologics, Inc., Bausch + Lomb Incorporated and Lannett Company Inc amongst others.
The List of Companies - Irritable Bowel Syndrome (IBS) Treatment Market
- Ironwood Pharmaceuticals, Inc.
- AbbVie.
- Sebela Pharmaceuticals, Inc.
- Takeda Pharmaceutical Company Limited
- Alfasigma S.p.A.
- Astellas Pharma Inc.
- AstraZeneca
- Synthetic Biologics, Inc.
- Bausch + Lomb Incorporated
- Lannett Company Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
May 2021
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2021
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
May 2021
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
May 2021
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2021
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2021
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
May 2021
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
May 2021
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)